Chaging Dynamics of The Healthcare M&A

The advent of M&A in the healthcare spectrum is not new however, after COVID-19 the government has taken measures to promote policies that favor more technological and innovative developments along with more acquisition prospects. This change has propelled rapid growth not only in the development and release of vaccines but also in other healthcare niches. Some of these policies helped some companies and some of them did not so much. This effect is becoming more evident in healthcare M&A. The tide turned towards the buyers market and more businesses understand the synergies that accrue with collaboration. More money is chasing the deals, however, finding that one good deal that fits your investment portfolio is the key. And that's what separates Big winners from just winners..!


P.S. How to find that winning deal... Continued in Part II